Jan Fallingborg

4.3k total citations · 2 hit papers
58 papers, 2.8k citations indexed

About

Jan Fallingborg is a scholar working on Genetics, Epidemiology and Surgery. According to data from OpenAlex, Jan Fallingborg has authored 58 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Genetics, 24 papers in Epidemiology and 20 papers in Surgery. Recurrent topics in Jan Fallingborg's work include Inflammatory Bowel Disease (28 papers), Microscopic Colitis (20 papers) and Eosinophilic Esophagitis (8 papers). Jan Fallingborg is often cited by papers focused on Inflammatory Bowel Disease (28 papers), Microscopic Colitis (20 papers) and Eosinophilic Esophagitis (8 papers). Jan Fallingborg collaborates with scholars based in Denmark, Australia and United Kingdom. Jan Fallingborg's co-authors include Bent Ascanius Jacobsen, Lisbet Ambrosius Christensen, H.H. Rasmussen, Sten Nørby Rasmussen, Henrik Højgaard Rasmussen, K. ABILDGAARD, Margrethe Ingeman‐Nielsen, Tine Jess, Lars Kristian Munck and Jens Kjeldsen and has published in prestigious journals such as Gastroenterology, Gut and The American Journal of Gastroenterology.

In The Last Decade

Jan Fallingborg

52 papers receiving 2.7k citations

Hit Papers

Intraluminal pH of the human gastrointestinal tract. 1999 2026 2008 2017 1999 2013 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Intraluminal pH of the human gastrointestinal tract.
    1999 529 citations Jan Fallingborg PubMed profile →
  2. Individualised therapy is more cost-effective than dose intensification in patients with Crohn’s disease who lose response to anti-TNF treatment: a randomised, controlled trial
    2013 361 citations Casper Steenholdt, Jørn Brynskov et al. Gut profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jan Fallingborg Denmark 21 1.2k 965 712 427 386 58 2.8k
Bent Ascanius Jacobsen Denmark 23 1.1k 0.9× 770 0.8× 589 0.8× 465 1.1× 279 0.7× 49 2.2k
Lisbet Ambrosius Christensen Denmark 29 1.3k 1.1× 1.1k 1.1× 829 1.2× 768 1.8× 517 1.3× 73 3.1k
Carsten Schmidt Germany 29 1.3k 1.1× 926 1.0× 722 1.0× 578 1.4× 233 0.6× 105 3.2k
J. Rhodes United Kingdom 33 617 0.5× 694 0.7× 1.1k 1.5× 630 1.5× 665 1.7× 112 3.4k
Angelo Viscido Italy 33 1.8k 1.5× 1.6k 1.6× 1.1k 1.6× 212 0.5× 428 1.1× 97 3.0k
Vineet Ahuja India 30 1.1k 0.9× 771 0.8× 1.1k 1.6× 374 0.9× 442 1.1× 132 2.9k
Pieter Hindryckx Belgium 28 2.1k 1.7× 1.5k 1.6× 1.1k 1.6× 535 1.3× 349 0.9× 88 3.5k
Charlie W. Lees United Kingdom 29 2.5k 2.1× 1.7k 1.8× 1.0k 1.5× 752 1.8× 242 0.6× 133 4.0k
R. Caprilli Italy 40 2.8k 2.4× 2.1k 2.2× 2.2k 3.1× 516 1.2× 680 1.8× 132 5.4k
Giulia Roda Italy 28 1.5k 1.3× 932 1.0× 666 0.9× 745 1.7× 166 0.4× 71 3.0k

Countries citing papers authored by Jan Fallingborg

Since Specialization
Citations

This map shows the geographic impact of Jan Fallingborg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Fallingborg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Fallingborg more than expected).

Fields of papers citing papers by Jan Fallingborg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan Fallingborg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Fallingborg. The network helps show where Jan Fallingborg may publish in the future.

Co-authorship network of co-authors of Jan Fallingborg

This figure shows the co-authorship network connecting the top 25 collaborators of Jan Fallingborg. A scholar is included among the top collaborators of Jan Fallingborg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan Fallingborg. Jan Fallingborg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Deleuran, Thomas, et al.. (2025). The effect of proton-pump inhibitor therapy on disease outcomes in inflammatory bowel disease: a population-based cohort study. Therapeutic Advances in Gastroenterology. 18. 1128576860–1128576860.
2.
Larsen, Lone, Jan Fallingborg, Bent Ascanius Jacobsen, et al.. (2023). Has the Incidence of Inflammatory Bowel Disease Peaked? Evidence From the Population-Based NorDIBD Cohort 1978–2020. The American Journal of Gastroenterology. 118(3). 501–510. 23 indexed citations
3.
Frigstad, Svein Oskar, Anne Haaber, Antal Bajor, et al.. (2017). The NIMO Scandinavian Study: A Prospective Observational Study of Iron Isomaltoside Treatment in Patients with Iron Deficiency. Gastroenterology Research and Practice. 2017. 1–7. 16 indexed citations
4.
Steenholdt, Casper, Jørn Brynskov, Ole Østergaard Thomsen, et al.. (2015). Individualized Therapy Is a Long-Term Cost-Effective Method Compared to Dose Intensification in Crohn’s Disease Patients Failing Infliximab. Digestive Diseases and Sciences. 60(9). 2762–2770. 64 indexed citations
5.
Julsgaard, Mette, Lisbet Ambrosius Christensen, Peter G. Gibson, et al.. (2014). Adalimumab and Infliximab levels in neonates correlate with duration of treatment in pregnancy (ERA study). United European Gastroenterology Journal. 29. 117–118. 1 indexed citations
6.
Steenholdt, Casper, Jørn Brynskov, Ole Østergaard Thomsen, et al.. (2013). Individualised therapy is more cost-effective than dose intensification in patients with Crohn’s disease who lose response to anti-TNF treatment: a randomised, controlled trial. Gut. 63(6). 919–927. 361 indexed citations breakdown →
7.
Jess, Tine, Erzsébet Horváth–Puhó, Jan Fallingborg, H.H. Rasmussen, & Bent Ascanius Jacobsen. (2013). Cancer Risk in Inflammatory Bowel Disease According to Patient Phenotype and Treatment: A Danish Population-Based Cohort Study. The American Journal of Gastroenterology. 108(12). 1869–1876. 182 indexed citations
8.
Jacobsen, Bent Ascanius, Jan Fallingborg, H.H. Rasmussen, et al.. (2006). Increase in incidence and prevalence of inflammatory bowel disease in northern Denmark: a population-based study, 1978???2002. European Journal of Gastroenterology & Hepatology. 18(6). 601–606. 117 indexed citations
9.
Vilien, M., Jens Frederik Dahlerup, Lars Kristian Munck, et al.. (2004). Randomized controlled azathioprine withdrawal after more than two years treatment in Crohn's disease: increased relapse rate the following year. Alimentary Pharmacology & Therapeutics. 19(11). 1147–1152. 57 indexed citations
10.
Fallingborg, Jan, et al.. (1998). Small Intestinal Transit Time and Intraluminal pH in Ileocecal Resected Patients with Crohn's Disease. Digestive Diseases and Sciences. 43(4). 702–705. 81 indexed citations
11.
Christensen, Lisbet Ambrosius, Jan Fallingborg, Bent Ascanius Jacobsen, et al.. (1994). Comparative bioavailability of 5‐aminosalicylic acid from a controlled release preparation and an azo‐bond preparation. Alimentary Pharmacology & Therapeutics. 8(3). 289–294. 28 indexed citations
12.
Fallingborg, Jan, et al.. (1993). Very low intraluminal colonic pH in patients with active ulcerative colitis. Digestive Diseases and Sciences. 38(11). 1989–1993. 183 indexed citations
13.
Fallingborg, Jan, Laurids Østergaard Poulsen, Anni Grove, & P. Stubbe Teglbjærg. (1992). Frequency ofHelicobacter pyloriand Gastritis in Healthy Subjects without Gastrointestinal Symptoms. Scandinavian Journal of Gastroenterology. 27(5). 388–390. 10 indexed citations
14.
Jacobsen, Bent Ascanius, K. ABILDGAARD, Henrik Højgaard Rasmussen, et al.. (1991). Availability of Mesalazine (5-Aminosalicylic Acid) from Enemas and Suppositories during Steady-State Conditions. Scandinavian Journal of Gastroenterology. 26(4). 374–378. 30 indexed citations
15.
Bendtsen, Flemming, Niels Erik Ebbehøj, Jan Fallingborg, et al.. (1990). Duodenal ulcer healing on 2 g of sucralfate daily at bedtime compared to 1 g four times daily. Alimentary Pharmacology & Therapeutics. 4(1). 97–99.
16.
Fallingborg, Jan, Lisbet Ambrosius Christensen, Margrethe Ingeman‐Nielsen, et al.. (1990). Gastrointestinal pH and transit times in healthy subjects with ileostomy. Alimentary Pharmacology & Therapeutics. 4(3). 247–253. 20 indexed citations
17.
Fallingborg, Jan, Lisbet Ambrosius Christensen, Margrethe Ingeman‐Nielsen, et al.. (1989). pH‐Profile and regional transit times of the normal gut measured by a radiotelemetry device. Alimentary Pharmacology & Therapeutics. 3(6). 605–614. 193 indexed citations
18.
Brynskov, Jørn, V. Binder, P Riis, et al.. (1989). Low‐dose cyclosporin for Crohn's disease: implications for clinical trials. Alimentary Pharmacology & Therapeutics. 3(2). 135–142. 16 indexed citations
19.
Fallingborg, Jan, et al.. (1985). Atraumatic rupture of the spleen in periarteritis nodosa.. PubMed. 151(1). 85–7. 12 indexed citations
20.
Fallingborg, Jan, et al.. (1985). Glucagon treatment of external pancreatic fistula. A case report.. PubMed. 151(2). 183–4. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bent Ascanius Jacobsen Breakdown of academic impact, for papers by Lisbet Ambrosius Christensen Breakdown of academic impact, for papers by Carsten Schmidt Breakdown of academic impact, for papers by J. Rhodes Breakdown of academic impact, for papers by Angelo Viscido Breakdown of academic impact, for papers by Vineet Ahuja Breakdown of academic impact, for papers by Pieter Hindryckx Breakdown of academic impact, for papers by Charlie W. Lees Breakdown of academic impact, for papers by R. Caprilli Breakdown of academic impact, for papers by Giulia Roda
Rankless by CCL
2026